COLLEGE OF MEDICINE AND HEALTH
Medicine, Nursing and Allied Health Professions

Loading content
Dr Kash Patel

Dr Kash Patel

Academic Clinical Lecturer

 +44 1392 408237

 RILD Building 

 

University of Exeter Medical School, RILD Building, RD&E Hospital Wonford, Barrack Road, Exeter, EX2 5DW, UK

Overview

Kash Patel is a Wellcome Trust Career Development Fellow and physician in Diabetes and Endocrinology. His main area of research includes understanding the genetics of diabetes with a focus on Monogenic and Type 1 diabetes. His research uses next-generation sequencing technology and large data sets to improve diagnosis and understanding of monogenic diaebtes in humans. He was a Wellcome Trust PhD Research Fellow in prestigious MRC Protein Phosphorylation unit in Dundee where he was awarded his PhD studying the glucose metabolism in the liver.  He closely works with by Professor Andrew Hattersley and Professor Sian Ellard at the University of Exeter Medical School. He is the receipient of prestigious Young Investigator awards from Diabetes UK and EASD-SGGD for his work in monogenic diabetes.

Qualifications

MBBS, MRCP, PhD

Research

Research interests

Dr Patel presents his research into identifying new genes that can cause young onset monogenic diabetes (diabetes caused by a defect in a single gene) in the video below. This talk was recorded at the Living Systems Institute Research Symposium in March 2016.

Publications

Key publications | Publications by category | Publications by year

Publications by category


Journal articles

Wright CF, West B, Tuke M, Jones SE, Patel K, Laver TW, Beaumont RN, Tyrrell J, Wood AR, Frayling TM, et al (2019). Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting. American Journal of Human Genetics, 104(2), 275-286. Abstract.  Full text.
Novak A, Bowman P, Kraljevic I, Tripolski M, Houghton JAL, De Franco E, Shepherd MH, Skrabic V, Patel KA (2019). Transient Neonatal Diabetes: an Etiologic Clue for the Adult Diabetologist. Can J Diabetes Author URL.
Johnson MB, De Franco E, Greeley SAW, Letourneau LR, Gillespie KM, International DS-PNDM Consortium, Wakeling MN, Ellard S, Flanagan SE, Patel KA, et al (2019). Trisomy 21 is a Cause of Permanent Neonatal Diabetes That is Autoimmune but Not HLA Associated. Diabetes, 68(7), 1528-1535. Abstract.  Author URL.  Full text.
Patel KA, Knight B, Aziz A, Babiker T, Tamar A, Findlay J, Cox S, Dimitropoulos I, Tysoe C, Panicker V, et al (2019). Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy. Clinical Endocrinology, 90(2), 328-333. Abstract.
Patel KA, Weedon MN, Shields BM, Pearson ER, Hattersley AT, McDonald TJ (2019). Zinc transporter 8 autoantibodies (ZnT8A) and a type 1 diabetes genetic risk score can exclude individuals with type 1 diabetes from inappropriate genetic testing for monogenic diabetes. Diabetes Care, 42(2), E16-E17.
Shepherd MH, Shields BM, Hudson M, Pearson ER, Hyde C, Ellard S, Hattersley AT, Patel KA (2018). A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Diabetologia, 61(12), 2520-2527. Abstract.  Full text.
Johnson MB, Patel KA, De Franco E, Houghton JAL, McDonald TJ, Ellard S, Flanagan SE, Hattersley AT (2018). A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes. Diabetologia, 61(4), 862-869. Abstract.  Full text.
Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, et al (2018). Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. The Lancet Diabetes and Endocrinology, 6(8), 637-646. Abstract.  Full text.
Cameron AR, Logie L, Patel K, Erhardt S, Bacon S, Middleton P, Harthill J, Forteath C, Coats JT, Kerr C, et al (2018). Metformin selectively targets redox control of complex I energy transduction. Redox Biology, 14, 187-197. Abstract.
Laver TW, Patel KA, Colclough K, Curran J, Dale J, Davis N, Savage DB, Flanagan SE, Ellard S, Hattersley AT, et al (2018). PLIN1 Haploinsufficiency is Not Associated with Lipodystrophy. Journal of Clinical Endocrinology and Metabolism, 103(9), 3225-3230. Abstract.  Full text.
Locke JM, Saint-Martin C, Laver TW, Patel KA, Wood AR, Sharp SA, Ellard S, Bellanné-Chantelot C, Hattersley AT, Harries LW, et al (2018). The common HNF1A variant I27L is a modifier of age at diabetes diagnosis in individuals with HNF1A-MOdy. Diabetes, 67(9), 1903-1907. Abstract.  Full text.
Patel KA, Kettunen J, Laakso M, Stančáková A, Laver TW, Colclough K, Johnson MB, Abramowicz M, Groop L, Miettinen PJ, et al (2017). Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance. Nature Communications, 8(1). Abstract.  Full text.
Day JO, Flanagan SE, Shepherd MH, Patrick AW, Abid N, Torrens L, Zeman AJ, Patel KA, Hattersley AT (2017). Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes. Diabetic Medicine, 34(7), 1000-1004. Abstract.  Full text.
Patel KA, Warren R, Brooke A, Aziz A, Avades T, Poyner R, Vaidya B (2017). Interpretation of thyroid scintigraphy is inconsistent among endocrinologists. Journal of Endocrinological Investigation, 40(10), 1155-1157. Full text.
Hattersley AT, Patel KA (2017). Precision diabetes: learning from monogenic diabetes. Diabetologia, 60(5), 769-777. Abstract.  Full text.
Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, Hattersley AT, Weedon MN (2016). A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care, 39(3), 337-344. Abstract.  Full text.
Fendler W, Madzio J, Kozinski K, Patel K, Janikiewicz J, Szopa M, Tracz A, Borowiec M, Jarosz-Chobot P, Mysliwiec M, et al (2016). Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors. Diabetologia, 59(7), 1463-1473. Abstract.  Full text.
Cameron AR, Logie L, Patel K, Bacon S, Forteath C, Harthill J, Roberts A, Sutherland C, Stewart D, Viollet B, et al (2016). Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1862(8), 1412-1422. Abstract.
Majithia AR, Tsuda B, Agostini M, Gnanapradeepan K, Rice R, Peloso G, Patel KA, Zhang X, Broekema MF, Patterson N, et al (2016). Prospective functional classification of all possible missense variants in PPARG. Nature Genetics, 48(12), 1570-1575. Abstract.
Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, et al (2016). Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia, 59(6), 1162-1166. Abstract.  Full text.
Laver TW, Colclough K, Shepherd M, Patel K, Houghton JAL, Dusatkova P, Pruhova S, Morris AD, Palmer CN, McCarthy MI, et al (2016). The common p.R114W HNF4A mutation causes a distinct clinical subtype of monogenic diabetes. Diabetes, 65(10), 3212-3217. Abstract.  Full text.
Patel KA, Oram RA, Flanagan SE, De Franco E, Colclough K, Shepherd M, Ellard S, Weedon MN, Hattersley AT (2016). Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes. Diabetes, 65(7), 2094-2099. Abstract.  Full text.
Patel K, Foretz M, Marion A, Campbell DG, Gourlay R, Boudaba N, Tournier E, Titchenell P, Peggie M, Deak M, et al (2014). The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. NATURE COMMUNICATIONS, 5 Author URL.  Full text.
von Wilamowitz-Moellendorff A, Hunter RW, Garcia-Rocha M, Kang L, Lopez-Soldado I, Lantier L, Patel K, Peggie MW, Martinez-Pons C, Voss M, et al (2013). Glucose-6-Phosphate-Mediated Activation of Liver Glycogen Synthase Plays a Key Role in Hepatic Glycogen Synthesis. DIABETES, 62(12), 4070-4082. Author URL.
Logie L, Harthill J, Patel K, Bacon S, Hamilton DL, Macrae K, McDougall G, Wang H-H, Xue L, Jiang H, et al (2012). Cellular Responses to the Metal-Binding Properties of Metformin. DIABETES, 61(6), 1423-1433. Author URL.
Henriksson E, Jones HA, Patel K, Peggie M, Morrice N, Sakamoto K, Goransson O (2012). The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser(358) in adipocytes. BIOCHEMICAL JOURNAL, 444, 503-514. Author URL.
Gajjar K, Patel K, Rao CA (2011). Thyroid disease in pregnancy. The Obstetrician & Gynaecologist, 11(2), 150-151.

Conferences

Patel KA, Thomas N, Walkey H, Kaur A, Williams A, Misra S, Bingley P, Oliver N, Johnston D, Hattersley AT, et al (2019). The initial clinical diagnosis of Type 1 diabetes is incorrect in one in eight people: Islet autoantibodies but not presenting features help identifying misdiagnosed people.  Author URL.
Hughes AE, Patel KA, Lowe LP, Jr LWL, Dunne FP, Hattersley AT, Freathy RM (2018). Women with isolated fasting hyperglycaemia in pregnancy are at a higher genetic risk for diabetes type 2.  Author URL.
Johnson MB, Patel KA, De Franco E, Flanagan SE, Ellard S, Hattersley AT (2017). A type 1 diabetes genetic risk score discriminatesmonogenic autoimmune diabetes from polygenic clustering of diabetes and autoimmunity.  Author URL.
Grubb AL, Patel KA, Oram RA, Hill AV, Angwin C, McDonald TJ, Weedon MN, Hattersley AT, Shields BV, Jones AG, et al (2017). Development of a risk calculator to identify patients with Type 1 diabetes who will require early insulin therapy.  Author URL.
Patel KA, Sheppard M, Lockett H, Hattersley AT, Walker JN (2017). Insulin pump therapy: a clinically and cost effective alternative for a patient with severe insulin resistance and minimal endogenous insulin secretion.  Author URL.
Bowman P, Shepherd MH, Babiker T, Flanagan SE, Houghton JAL, Mathews F, Patel KA, Thomas NJ, Ellard S, Hattersley AT, et al (2017). Sulphonylureas are a highly effective long-term treatment for KCNJ11 neonatal diabetes: the first 10 year follow-up study of a large international cohort.  Author URL.
Patel KA, Hill A, Shields BM, Oram RA, Jones A, Hattersley AT (2017). Type 2 diabetes and severe insulin deficiency.  Author URL.
Patel KA, Oram RA, Mcdonald TJ, Hudson M, Colclough K, Ellard S, Weedon MN, Pearson EZ, Hattersley AT (2016). Classifying the unclassified using Type 1 diabetes genetic risk score: patients with young onset diabetes who are islet autoantibody negative and have preserved c-peptide.  Author URL.
Patel KA, Laver T, Johnson M, Sanders T, Shepherd M, Ellard S, Flanagan S, Hattersley AT, Weedon MN (2016). RFX6 is a new MODY gene.  Author URL.
Weedon MN, Hill AV, McDonald TJ, Patel KA, Jones A, Hattersley AT, Oram R (2015). A novel inexpensive test can discriminate between Type 1 and Type 2 diabetes.  Author URL.
Babiker T, Patel KA, Chakera AJ, Houghton J, Shepherd MH, Ellard S, Hattersley AT (2015). Predicting successful transfer to sulphonylureas in neonatal diabetes caused by KCNJ11 mutations.  Author URL.
Patel KA, Weedon MN, Ellard S, Hattersley AT, Oram RA (2015). Type 1 diabetes genetic risk score: a novel tool to differentiate monogenic diabetes from Type 1 diabetes.  Author URL.

Publications by year


2019

Wright CF, West B, Tuke M, Jones SE, Patel K, Laver TW, Beaumont RN, Tyrrell J, Wood AR, Frayling TM, et al (2019). Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting. American Journal of Human Genetics, 104(2), 275-286. Abstract.  Full text.
Patel KA, Thomas N, Walkey H, Kaur A, Williams A, Misra S, Bingley P, Oliver N, Johnston D, Hattersley AT, et al (2019). The initial clinical diagnosis of Type 1 diabetes is incorrect in one in eight people: Islet autoantibodies but not presenting features help identifying misdiagnosed people.  Author URL.
Novak A, Bowman P, Kraljevic I, Tripolski M, Houghton JAL, De Franco E, Shepherd MH, Skrabic V, Patel KA (2019). Transient Neonatal Diabetes: an Etiologic Clue for the Adult Diabetologist. Can J Diabetes Author URL.
Johnson MB, De Franco E, Greeley SAW, Letourneau LR, Gillespie KM, International DS-PNDM Consortium, Wakeling MN, Ellard S, Flanagan SE, Patel KA, et al (2019). Trisomy 21 is a Cause of Permanent Neonatal Diabetes That is Autoimmune but Not HLA Associated. Diabetes, 68(7), 1528-1535. Abstract.  Author URL.  Full text.
Patel KA, Knight B, Aziz A, Babiker T, Tamar A, Findlay J, Cox S, Dimitropoulos I, Tysoe C, Panicker V, et al (2019). Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy. Clinical Endocrinology, 90(2), 328-333. Abstract.
Patel KA, Weedon MN, Shields BM, Pearson ER, Hattersley AT, McDonald TJ (2019). Zinc transporter 8 autoantibodies (ZnT8A) and a type 1 diabetes genetic risk score can exclude individuals with type 1 diabetes from inappropriate genetic testing for monogenic diabetes. Diabetes Care, 42(2), E16-E17.

2018

Shepherd MH, Shields BM, Hudson M, Pearson ER, Hyde C, Ellard S, Hattersley AT, Patel KA (2018). A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Diabetologia, 61(12), 2520-2527. Abstract.  Full text.
Johnson MB, Patel KA, De Franco E, Houghton JAL, McDonald TJ, Ellard S, Flanagan SE, Hattersley AT (2018). A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes. Diabetologia, 61(4), 862-869. Abstract.  Full text.
Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, et al (2018). Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study. The Lancet Diabetes and Endocrinology, 6(8), 637-646. Abstract.  Full text.
Cameron AR, Logie L, Patel K, Erhardt S, Bacon S, Middleton P, Harthill J, Forteath C, Coats JT, Kerr C, et al (2018). Metformin selectively targets redox control of complex I energy transduction. Redox Biology, 14, 187-197. Abstract.
Laver TW, Patel KA, Colclough K, Curran J, Dale J, Davis N, Savage DB, Flanagan SE, Ellard S, Hattersley AT, et al (2018). PLIN1 Haploinsufficiency is Not Associated with Lipodystrophy. Journal of Clinical Endocrinology and Metabolism, 103(9), 3225-3230. Abstract.  Full text.
Locke JM, Saint-Martin C, Laver TW, Patel KA, Wood AR, Sharp SA, Ellard S, Bellanné-Chantelot C, Hattersley AT, Harries LW, et al (2018). The common HNF1A variant I27L is a modifier of age at diabetes diagnosis in individuals with HNF1A-MOdy. Diabetes, 67(9), 1903-1907. Abstract.  Full text.
Hughes AE, Patel KA, Lowe LP, Jr LWL, Dunne FP, Hattersley AT, Freathy RM (2018). Women with isolated fasting hyperglycaemia in pregnancy are at a higher genetic risk for diabetes type 2.  Author URL.

2017

Johnson MB, Patel KA, De Franco E, Flanagan SE, Ellard S, Hattersley AT (2017). A type 1 diabetes genetic risk score discriminatesmonogenic autoimmune diabetes from polygenic clustering of diabetes and autoimmunity.  Author URL.
Grubb AL, Patel KA, Oram RA, Hill AV, Angwin C, McDonald TJ, Weedon MN, Hattersley AT, Shields BV, Jones AG, et al (2017). Development of a risk calculator to identify patients with Type 1 diabetes who will require early insulin therapy.  Author URL.
Patel KA, Kettunen J, Laakso M, Stančáková A, Laver TW, Colclough K, Johnson MB, Abramowicz M, Groop L, Miettinen PJ, et al (2017). Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance. Nature Communications, 8(1). Abstract.  Full text.
Day JO, Flanagan SE, Shepherd MH, Patrick AW, Abid N, Torrens L, Zeman AJ, Patel KA, Hattersley AT (2017). Hyperglycaemia-related complications at the time of diagnosis can cause permanent neurological disability in children with neonatal diabetes. Diabetic Medicine, 34(7), 1000-1004. Abstract.  Full text.
Patel KA, Sheppard M, Lockett H, Hattersley AT, Walker JN (2017). Insulin pump therapy: a clinically and cost effective alternative for a patient with severe insulin resistance and minimal endogenous insulin secretion.  Author URL.
Patel KA, Warren R, Brooke A, Aziz A, Avades T, Poyner R, Vaidya B (2017). Interpretation of thyroid scintigraphy is inconsistent among endocrinologists. Journal of Endocrinological Investigation, 40(10), 1155-1157. Full text.
Hattersley AT, Patel KA (2017). Precision diabetes: learning from monogenic diabetes. Diabetologia, 60(5), 769-777. Abstract.  Full text.
Bowman P, Shepherd MH, Babiker T, Flanagan SE, Houghton JAL, Mathews F, Patel KA, Thomas NJ, Ellard S, Hattersley AT, et al (2017). Sulphonylureas are a highly effective long-term treatment for KCNJ11 neonatal diabetes: the first 10 year follow-up study of a large international cohort.  Author URL.
Patel KA, Hill A, Shields BM, Oram RA, Jones A, Hattersley AT (2017). Type 2 diabetes and severe insulin deficiency.  Author URL.

2016

Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, Hattersley AT, Weedon MN (2016). A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care, 39(3), 337-344. Abstract.  Full text.
Patel KA, Oram RA, Mcdonald TJ, Hudson M, Colclough K, Ellard S, Weedon MN, Pearson EZ, Hattersley AT (2016). Classifying the unclassified using Type 1 diabetes genetic risk score: patients with young onset diabetes who are islet autoantibody negative and have preserved c-peptide.  Author URL.
Fendler W, Madzio J, Kozinski K, Patel K, Janikiewicz J, Szopa M, Tracz A, Borowiec M, Jarosz-Chobot P, Mysliwiec M, et al (2016). Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors. Diabetologia, 59(7), 1463-1473. Abstract.  Full text.
Cameron AR, Logie L, Patel K, Bacon S, Forteath C, Harthill J, Roberts A, Sutherland C, Stewart D, Viollet B, et al (2016). Investigation of salicylate hepatic responses in comparison with chemical analogues of the drug. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1862(8), 1412-1422. Abstract.
Majithia AR, Tsuda B, Agostini M, Gnanapradeepan K, Rice R, Peloso G, Patel KA, Zhang X, Broekema MF, Patterson N, et al (2016). Prospective functional classification of all possible missense variants in PPARG. Nature Genetics, 48(12), 1570-1575. Abstract.
Patel KA, Laver T, Johnson M, Sanders T, Shepherd M, Ellard S, Flanagan S, Hattersley AT, Weedon MN (2016). RFX6 is a new MODY gene.  Author URL.
Babiker T, Vedovato N, Patel K, Thomas N, Finn R, Männikkö R, Chakera AJ, Flanagan SE, Shepherd MH, Ellard S, et al (2016). Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia, 59(6), 1162-1166. Abstract.  Full text.
Laver TW, Colclough K, Shepherd M, Patel K, Houghton JAL, Dusatkova P, Pruhova S, Morris AD, Palmer CN, McCarthy MI, et al (2016). The common p.R114W HNF4A mutation causes a distinct clinical subtype of monogenic diabetes. Diabetes, 65(10), 3212-3217. Abstract.  Full text.
Patel KA, Oram RA, Flanagan SE, De Franco E, Colclough K, Shepherd M, Ellard S, Weedon MN, Hattersley AT (2016). Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes. Diabetes, 65(7), 2094-2099. Abstract.  Full text.

2015

Weedon MN, Hill AV, McDonald TJ, Patel KA, Jones A, Hattersley AT, Oram R (2015). A novel inexpensive test can discriminate between Type 1 and Type 2 diabetes.  Author URL.
Babiker T, Patel KA, Chakera AJ, Houghton J, Shepherd MH, Ellard S, Hattersley AT (2015). Predicting successful transfer to sulphonylureas in neonatal diabetes caused by KCNJ11 mutations.  Author URL.
Patel KA, Weedon MN, Ellard S, Hattersley AT, Oram RA (2015). Type 1 diabetes genetic risk score: a novel tool to differentiate monogenic diabetes from Type 1 diabetes.  Author URL.

2014

Patel K, Foretz M, Marion A, Campbell DG, Gourlay R, Boudaba N, Tournier E, Titchenell P, Peggie M, Deak M, et al (2014). The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. NATURE COMMUNICATIONS, 5 Author URL.  Full text.

2013

von Wilamowitz-Moellendorff A, Hunter RW, Garcia-Rocha M, Kang L, Lopez-Soldado I, Lantier L, Patel K, Peggie MW, Martinez-Pons C, Voss M, et al (2013). Glucose-6-Phosphate-Mediated Activation of Liver Glycogen Synthase Plays a Key Role in Hepatic Glycogen Synthesis. DIABETES, 62(12), 4070-4082. Author URL.

2012

Logie L, Harthill J, Patel K, Bacon S, Hamilton DL, Macrae K, McDougall G, Wang H-H, Xue L, Jiang H, et al (2012). Cellular Responses to the Metal-Binding Properties of Metformin. DIABETES, 61(6), 1423-1433. Author URL.
Henriksson E, Jones HA, Patel K, Peggie M, Morrice N, Sakamoto K, Goransson O (2012). The AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser(358) in adipocytes. BIOCHEMICAL JOURNAL, 444, 503-514. Author URL.

2011

Gajjar K, Patel K, Rao CA (2011). Thyroid disease in pregnancy. The Obstetrician & Gynaecologist, 11(2), 150-151.

Kashyap_Patel Details from cache as at 2019-08-17 08:34:48

Refresh publications

Teaching

Supervision / Group

Back | Edit Profile